Oramed Pharmaceuticals OTC:ORMP.OB is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an oral insulin capsule currently in Phase trials, the Company is seeking to revolutionize the treatment of diabetes.
Quote | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
Last: | $2.46 |
---|---|
Change Percent: | -0.87% |
Open: | $2.32 |
Close: | $2.46 |
High: | $2.48 |
Low: | $2.31 |
Volume: | 84,424 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
PALO ALTO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today...
2024-03-07 10:53:47 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ: ORMP ) just reported results for the fourth quarter of 2023. Oramed Pharmaceuticals reported earnings per share of 33 cents. This was above...
Message Board Posts | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
Subject | By | Source | When |
---|---|---|---|
I agree - I will be happy if | Amatuer17 | investorshub | 05/15/2023 2:49:52 PM |
I am completely out of this stock | midastouch017 | investorshub | 05/15/2023 2:42:47 PM |
That is good news for Oramed - not | Amatuer17 | investorshub | 05/15/2023 2:38:29 PM |
3.8200+0.9900 (+34.9823%) | midastouch017 | investorshub | 05/15/2023 1:51:05 PM |
Oramed Announces that its Chinese Partner, HTIT, has | midastouch017 | investorshub | 05/15/2023 1:22:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Oramed Pharmaceuticals Inc. Company Name:
ORMP Stock Symbol:
NASDAQ Market:
Oramed Pharmaceuticals Inc. Website:
PALO ALTO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today...
Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...